bluebird bio BLUE is set to give its latest quarterly earnings report on Thursday, 2024-11-14. Here's what investors need to know before the announcement. Analysts estimate that bluebird bio will ...

Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these ...

Blue Bird is a Strong Buy with a $91 target, driven by its monopoly on alternative-fueled buses and robust financial health.

StockNews.com upgraded shares of Blue Bird (NASDAQ:BLBD – Free Report) from a hold rating to a buy rating in a report released on Friday morning. BLBD has been the subject of several other research ...

JP Morgan has recently reduced bluebird bio Inc (BLUE) stock to Neutral rating, as announced on August 15, 2024, according to Finviz. Earlier, on December 11, 2023, HSBC Securities had reduced the ...

Axxcess Wealth Management LLC bought a new position in shares of Blue Bird Co. (NASDAQ:BLBD – Free Report) during the third quarter, according to its most recent disclosure with the Securities and ...

Press-Register columnist Kathy Jumper runs down interesting real estate deals for Mobile and the surrounding area in her ...

Needham analyst Chris Pierce reiterated a Buy rating on Blue Bird (BLBD – Research Report) today and set a price target of $66.00. Chris ...

Bluebird Bio ( (BLUE) ) has issued an announcement. At bluebird bio, Inc.’s 2024 Annual Meeting, key decisions included increasing the ...

SOMERVILLE, Mass., November 06, 2024--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today announced that it partially adjourned its annual meeting of stockholders ("Annual ...

Jakarta . Taxi operator Blue Bird (IDX: BIRD) reported a revenue of Rp 3.66 trillion for the third quarter of 2024, marking a ...

On Tuesday, bluebird bio Inc (BLUE) stock saw a decline, ending the day at $0.45 which represents a decrease of $-0.01 or -2.17% from the prior close of $0.46. The stock opened at $0.46 and touched a ...